Cell proliferation induced by modified cationic dextran
暂无分享,去创建一个
Maria Nowakowska | Kamil Kaminski | Krystyna Stalinska | Anna Niziolek | Maria Wróbel | Marta Kaczor-Kaminska
[1] A. Wellstein,et al. Enhancement of Fibroblast Growth Factor (FGF) Activity by an FGF-binding Protein* , 2001, The Journal of Biological Chemistry.
[2] Thomas Kissel,et al. In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis. , 2003, Biomaterials.
[3] S. M. Lewis,et al. Medical-Surgical Nursing , 1996, Definitions.
[4] M. Nowakowska,et al. Cationic derivative of dextran reverses anticoagulant activity of unfractionated heparin in animal models of arterial and venous thrombosis. , 2012, European journal of pharmacology.
[5] H. Meiselman,et al. Effects of dextran molecular weight on red blood cell aggregation. , 2008, Biophysical journal.
[6] W. Rosenblum. Effects of Dextran-40 on Blood Viscosity in Experimental Macroglobulinaemia , 1968, Nature.
[7] N. Mason,et al. A [polycation:heparin] complex releases growth factors with enhanced bioactivity. , 2011, Journal of controlled release : official journal of the Controlled Release Society.
[8] J. Elferink. Changes of plasma membrane permeability in neutrophils treated with polycations , 1991, Inflammation.
[9] J. Bereta,et al. Nonclinical Evaluation of Novel Cationically Modified Polysaccharide Antidotes for Unfractionated Heparin , 2015, PloS one.
[10] Richard Hoogenboom,et al. Cytotoxicity of polycations: Relationship of molecular weight and the hydrolytic theory of the mechanism of toxicity. , 2017, International journal of pharmaceutics.